PureTech Health (PRTC) Revenue & Revenue Breakdown
PureTech Health Revenue Highlights
Latest Revenue (Y)
$3.33M
Latest Revenue (Q)
$178.57K
PureTech Health Revenue by Period
PureTech Health Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $3.33M | 59.33% |
| 2022-12-31 | $2.09M | -79.06% |
| 2021-12-31 | $9.98M | 19.64% |
| 2020-12-31 | $8.34M | -3.99% |
| 2019-12-31 | $8.69M | -46.93% |
| 2018-12-31 | $16.37M | 2418.62% |
| 2017-12-31 | $650.00K | -85.33% |
| 2016-12-31 | $4.43M | -62.26% |
| 2015-12-31 | $11.74M | 483.50% |
| 2014-12-31 | $2.01M | -71.33% |
| 2013-12-31 | $7.02M | -11.51% |
| 2012-12-31 | $7.93M | - |
PureTech Health generated $3.33M in revenue during NA 2023, up 59.33% compared to the previous quarter, and up 20.34% compared to the same period a year ago.
PureTech Health Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $178.57K | 98.41% |
| 2023-09-30 | $90.00K | -97.14% |
| 2023-06-30 | $3.15M | 100.00% |
| 2023-03-31 | $1.57M | -82.52% |
| 2022-12-31 | $9.01M | 109.82% |
| 2022-09-30 | $4.29M | -38.93% |
| 2022-06-30 | $7.03M | 105.44% |
| 2020-06-30 | $3.42M | - |
PureTech Health generated $178.57K in revenue during Q4 2023, up 98.41% compared to the previous quarter, and up 4.16% compared to the same period a year ago.
PureTech Health Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| JANX | Janux Therapeutics | $8.08M | $8.90M |
| MOLN | Molecular Partners | $7.04M | $2.74M |
| PRTC | PureTech Health | $3.33M | $178.57K |
| MNOV | MediciNova | $1.00M | - |
| OPT | Opthea | $108.41K | $61.27K |
| ANEB | Anebulo Pharmaceuticals | - | - |
| RZLT | Rezolute | - | - |
| ACRV | Acrivon Therapeutics | - | - |
| MLYS | Mineralys Therapeutics | - | - |
| NUVB | Nuvation Bio | - | $727.00K |
| CSBR | Champions Oncology | - | $-14.06M |